p14ARF is associated with the regulation of p53 and MDM2 and is deleted or methylated in many human cancers.
| Institute |
|---|
| Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| Cat. #: | 151246 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell biology;Genetics |
| Application: | ELISA ; IHC ; IF ; IP ; WB |
| Target: | p14 ARF |
| Reactivity: | Human |
| Clone: | ARF 4C6/4 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | p14ARF is associated with the regulation of p53 and MDM2 and is deleted or methylated in many human cancers. The gene for CDK2NA generates several transcripts/proteins which differ from each other in their first exons. Three of these transcripts are generated by alternative splicing (isoform 1 a.k.a p16INK4A, isoform 2 and isoform 3 a.k.a p12), two of which are known to function as inhibitors of CDK4 kinase. One other transcript that is generated from this gene contains an alternate reading frame (ARF), with the first exon located 20kb upstream of the remainder of the gene(isoform 4 a.k.a. p14ARF, p19ARF, ARF). In spite of the structural and some functional differences, all the proteins encoded by the CDKN2A gene are involved in cell cycle G1 control. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Molecular weight: | 14 kDa |
| Immunogen: | His-tagged p14ARF protein expressed in bacteria. |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | p14ARF is associated with the regulation of p53 and MDM2 and is deleted or methylated in many human cancers. The gene for CDK2NA generates several transcripts/proteins which differ from each other in their first exons. Three of these transcripts are generated by alternative splicing (isoform 1 a.k.a p16INK4A, isoform 2 and isoform 3 a.k.a p12), two of which are known to function as inhibitors of CDK4 kinase. One other transcript that is generated from this gene contains an alternate reading frame (ARF), with the first exon located 20kb upstream of the remainder of the gene(isoform 4 a.k.a. p14ARF, p19ARF, ARF). In spite of the structural and some Fn differences, all the proteins encoded by the CDKN2A gene are involved in cell cycle G1 control. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | '-15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Ma et al. 2007. Mol Biol Cell. 18(7):2630-5. PMID: 17494866. Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway. p14ARF expression in invasive breast cancers and ductal carcinoma in situ–relationships to p53 and Hdm2. Vestey et al. 2004. Breast Cancer Res. 6(5):R571-85. PMID: 15318938. Clark et al. 2002. Oncogene. 21(29):4498-507. PMID: 12085228. Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2. Llanos et al. 2001. Nat Cell Biol. 3(5):445-52. PMID: 11331871. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.